Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-08-23
2011-11-22
Wen, Sharon (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S387300, C424S130100, C424S133100, C424S141100, C424S145100
Reexamination Certificate
active
08063188
ABSTRACT:
Monoclonal anti-myostatin antibodies that preferentially bind myostatin over GDF-11, have strong binding affinity to myostatin and are resistant to chemical degradation. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for the treatment or prevention of various disorders in mammalian and avian species.
REFERENCES:
patent: 5639638 (1997-06-01), Wozney et al.
patent: 5700911 (1997-12-01), Wozney et al.
patent: 5827733 (1998-10-01), Lee et al.
patent: 5914234 (1999-06-01), Lee et al.
patent: 6096506 (2000-08-01), Lee et al.
patent: 6340668 (2002-01-01), Celeste et al.
patent: 6368597 (2002-04-01), Strassmann et al.
patent: 6437111 (2002-08-01), Wozney et al.
patent: 6468535 (2002-10-01), Lee et al.
patent: 6500664 (2002-12-01), Lee et al.
patent: 6517835 (2003-02-01), Lee et al.
patent: 6656475 (2003-12-01), Lee et al.
patent: 6696260 (2004-02-01), Lee et al.
patent: 6858208 (2005-02-01), Lee et al.
patent: 7175997 (2007-02-01), Wozney et al.
patent: 7179884 (2007-02-01), Lee et al.
patent: 7261893 (2007-08-01), Veldman et al.
patent: 7320789 (2008-01-01), Dunham et al.
patent: 7371726 (2008-05-01), Junker et al.
patent: 7511012 (2009-03-01), Han et al.
patent: 7534432 (2009-05-01), Lee et al.
patent: 7585648 (2009-09-01), Junker et al.
patent: 2002/0150577 (2002-10-01), Lee et al.
patent: 2003/0138422 (2003-07-01), Aghajanian et al.
patent: 2004/0142382 (2004-07-01), Veldman et al.
patent: 2004/0181033 (2004-09-01), Han et al.
patent: 2005/0014733 (2005-01-01), Whittemore et al.
patent: 2005/0043232 (2005-02-01), Lee et al.
patent: 2005/0143306 (2005-06-01), Junker et al.
patent: 2006/0216279 (2006-09-01), Glass et al.
patent: 2006/0240487 (2006-10-01), Nowak et al.
patent: 2006/0263354 (2006-11-01), Chin et al.
patent: 2007/0087000 (2007-04-01), Walsh et al.
patent: 2007/0149458 (2007-06-01), Han et al.
patent: 2007/0178097 (2007-08-01), Presta
patent: 2007/0190056 (2007-08-01), Kambadur et al.
patent: 2008/0051328 (2008-02-01), Sharma et al.
patent: 2008/0187543 (2008-08-01), Kambadur et al.
patent: 2008/0299126 (2008-12-01), Han et al.
patent: 2009/0017045 (2009-01-01), Lee et al.
patent: 2009/0017522 (2009-01-01), Lee et al.
patent: 2009/0136481 (2009-05-01), Kambadur et al.
patent: 2009/0215671 (2009-08-01), Calof et al.
patent: 2009/0220491 (2009-09-01), Han et al.
patent: 2009/0311282 (2009-12-01), Junker et al.
patent: 1333035 (2003-08-01), None
patent: 0690873 (2003-11-01), None
patent: 0776337 (2005-09-01), None
patent: 2 333 706 (1999-04-01), None
patent: WO 94/21681 (1994-09-01), None
patent: WO 94/26892 (1994-11-01), None
patent: WO 96/01845 (1996-01-01), None
patent: 9835019 (1998-08-01), None
patent: WO 99/06559 (1999-02-01), None
patent: WO 99/24058 (1999-05-01), None
patent: WO 99/40181 (1999-08-01), None
patent: WO 99/42573 (1999-08-01), None
patent: WO 99/56768 (1999-11-01), None
patent: WO 00/43781 (2000-07-01), None
patent: WO 02/09641 (2002-02-01), None
patent: WO 02/10214 (2002-02-01), None
patent: WO 03/027248 (2003-04-01), None
patent: WO 2004/037861 (2004-05-01), None
patent: WO 2004/058988 (2004-07-01), None
patent: WO 2004/108157 (2004-12-01), None
patent: WO 2005/066204 (2005-07-01), None
patent: WO 2005/094446 (2005-10-01), None
patent: WO 2006/020884 (2006-02-01), None
patent: WO 2006/116269 (2006-11-01), None
patent: WO 2007/024535 (2007-03-01), None
patent: WO 2007/047112 (2007-04-01), None
patent: WO 2007/067616 (2007-06-01), None
patent: 2008109167 (2008-09-01), None
Wagner et al. (Annals of Neurology 2008, 63:561-571).
U.S. Appl. No. 12/066,838.
Ashmore, et al., “Comparative Aspects of Muscle Fiber Types in Fetuses of the Normal and ‘Double-Muscled’ Cattle,”Growth38:501-506 (1974).
Bogdanovich, et al., “Functional Improvement of Dystrophic Muscle by Myostatin Blockade,”Nature420:418-421 (2002).
Bogdanovich, et al., “Therapeutics for Duchenne Muscular Dystrophy: Current Approaches and Future Directions,”J. Mol. Med.82:102-115 (2004).
Gamer, et al., “Gdfl 1 is a Negative Regulator of Chondrogenesis and Myogenesis in the Developing Chick Limb,”Dev. Biol.229:407-420 (2001).
Gamer, et al., “A Novel BMP Expressed in Developing Mouse Limb, Spinal Cord, and Tail Bud Is a Potent Mesoderm Inducer inXenopusEmbryos,”Dev. Biol.208:222-232 (1999).
Gonzalez-Cadavid, et al., “Organization of the Human Myostatin Gene and Expression in Healthy Men and HIV-Infected Men With Muscle Wasting,”PNAS95:14938-14943 (1998).
Gonzales-Cadavid, et al., “Role of Myostatin in Metabolism,”Curr. Opin. Clin. Nutr. Metab. Care7:451-457 (2004).
Grobet, et al., “A Deletion in the Bovine Myostatin Gene Causes the Double-Muscled Phenotype in Cattle,”Nature Genet.17:71-74 (1997).
Hamrick, et al., “Femoral Morphology and Cross-Sectional Geometry of Adult Myostatin-Deficient Mice,”Bone27:343-349 (2000).
Hamrick, et al., “Bone Mineral Content and Density in the Humerus of Adult Myostatin-Deficient Mice,”Calcif. Tissue Int.71(1):63-68 (2002).
Hill, et al., “The Myostatin Propeptide and the Follistatin-Related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Scrum,”J. Biol. Chem.277:40735-40741 (2002).
Hill, et al., “Regulation of Myostatin in Vivo by Growth and Differentiation Factor-Associated Serum Protein-1: A Novel Protein with Protease Inhibitor and Follistatin Domains,”Mol. Endocrinol.17:1144-1154 (2003).
Hoodless, et al., “Mechanisms and Function of Signaling by the TGFβ Superfamily,”Current Topics in Microbiology and Immunologypp. 236-272 (1998).
Huet, et al., “Skeletal Muscle Cell Hypertrophy Induced by Inhibitors of Metalloproteases; Myostatin as a Potential Mediator,”Am. J. Physiol. Cell. Physiol.281:C1624-C1634 (2001).
Jiang, et al., “Characterization and Identification of the Inhibitory Domain of GDF-8 Propeptide,”Biochem. Biophys. Res. Commun.315:525-531 (2004).
Kambadur, et al., “Mutations inMyostatin(GDF8) In Double-Muscled Belgian Blue and Piedmontese Cattle,”Genome Res.7:910-915 (1997).
Kim, et al., “Inhibition of Preadipocyte Differentiation by Myostatin Treatment in 3T3-L1 Cultures,”Biochem. Biophys. Res. Comm., 281:902-906 (2001).
Kingsley, D.M., “The TGFβ Superfamily: New Members, New Receptors, and New Genetic Tests of Function in Different Organisms,”Genes&Devel.8:133-146 (1994).
Kirk, et al., “Myostatin Regulation During Skeletal Muscle Regeneration,”J. Cell. Physiol., 184:356-363 (2000).
Lang, et al., “Regulation of Myostatin by Glucocorticoids After Thermal Injury,”FASEB J.15:1807-1809 (2001).
Lee, et al., “Regulation of Myostatin Activity and Muscle Growth,”PNAS98:9306-9311 (2001).
Li, et al., “Elimination of Myostatin Does Not Combat Muscular Dystophy in dy Mice but Increases Postnatal Lethality,”AJP.166 (2) 491-497, 2005.
Lin, et al., “Myostatin Knockout in Mice Increases Myogenesis and Decreases Adipogenesis,”Biochem. Biophys. Res. Comm., 291:701-706 (2002).
Massagué, J., “The Transforming Growth Factor-β Family,”Ann. Rev. Cell Biol.6:597-641 (1990).
McPherron, et al., “Double Muscling in Cattle Due to Mutations in the Myostatin Gene,”PNAS94:12457-12461 (1997).
McPherron, et al., “Regulation of Skeletal Muscle Mass in Mice by a New TGF-β Superfamily Member,”Nature387:83-90 (1997).
McPherron, et al., “Suppression of Body Fat Accumulation in Myostatin-Deficient Mice,”J. Clin. Invest.109:595-601 (2002).
Muscaritoli, et al., “Therapy of Muscle Wasting in Cancer: What Is the Future?”Curr. Opin. Clin. Nutr. Metab. Care, 7:459-466 (2004).
Nakashima, et al., “Expression of Growth/Differentiation Factor 11, A New Member of the BMP/TGF β Superfamily During Mouse Embryogenesis,”Mech. Dev.80:185-189 (1999).
Reardon, et al., “Myostatin, Insulin-Like G
Huang Lihua
Sayers Robert Owen
Cox Gregory A.
Eli Lilly and Company
Wen Sharon
LandOfFree
Anti-myostatin antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-myostatin antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-myostatin antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280154